What the New HHS-Wide Nine-Application Cap Means for SBIR/STTR Companies
HHS will limit SBIR/STTR applicants to nine proposals annually, forcing companies to rethink submission volume and funding strategy.
Tag: NIH
HHS Just Added MAHA to Every Application. Most Applicants Will Miss Why That Matters.
HHS applicants are now encouraged to consider the MAHA Strategy. The language is optional, but the signal may not be.
NIH Parent NOFO Update
Certain NIH and FDA components no longer accept clinical trials through Parent NOFOs, creating major application screening risks.
HHS Moving to Clinical Trial Optional
HHS Parent NOFOs now use a clinical trial optional structure, simplifying application selection while changing proposal strategy.
NIH SBIR/STTR Budget Limits Vary More Than Most Applicants Realize
NIH budget limits vary significantly by Institute, creating funding opportunities ranging from Phase I awards to $15 million Phase IIBs.
NIH SBIR/STTR Returns With New Parent NOFOs, and a Few Important Signals for Applicants
NIH SBIR/STTR funding is back, but applicants should pay close attention to new structures, requirements, and emerging signals.
NIH’s Replication and Reproducibility Focus Is Reshaping How Strong Applications Are Recognized
NIH is reinforcing reproducibility expectations, shifting how reviewers assess credibility and forcing applicants to rethink how rigor is built into study design.
SBIR/STTR TABA Changes: More Than a Minor Budget Update
The new SBIR/STTR TABA rules change who can use funds, how they can be used, and why proposal strategy matters more.
NIH’s New 2026 DMS Plan Format Simplifies the Process, But Not the Expectation
NIH’s new DMS Plan format reduces narrative burden, but expectations for data sharing strategy and compliance remain firmly in place.
Government Shutdowns and Federal Grants: Why Strong Evaluation Keeps Your Project Moving Forward
A government shutdown can delay or disrupt federal grantmaking. The one thing you can control is how you prepare. Strong evaluation helps your project stay credible, measurable, and ready when funding resumes. EBHC has the track record to guide you through uncertain times.